These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 25075423)

  • 1. Characterization of a novel CYP2C9 mutation (1009C>A) detected in a warfarin-sensitive patient.
    Luo SB; Li CB; Dai DP; Wang SH; Wang ZH; Geng PW; Cai J; Jiang ZL; Pu CW; Shang K; Yuan XM; Cao YP; Hu GX; Cai JP
    J Pharmacol Sci; 2014; 125(2):150-6. PubMed ID: 25075423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification and characterization of a novel CYP2C9 allelic variant in a warfarin-sensitive patient.
    Dai DP; Li CB; Wang SH; Cai J; Geng PW; Zhou YF; Hu GX; Cai JP
    Pharmacogenomics; 2015; 16(13):1475-86. PubMed ID: 26255664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An identification and functional evaluation of a novel CYP2C9 variant CYP2C9*62.
    Chen H; Dai DP; Zhou S; Liu J; Wang SH; Wu HL; Zhou Q; Geng PW; Chong J; Lü Y; Cai JP; Yang JF
    Chem Biol Interact; 2020 Aug; 327():109168. PubMed ID: 32531309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification and Functional Assessment of a New CYP2C9 Allelic Variant CYP2C9*59.
    Dai DP; Wang SH; Li CB; Geng PW; Cai J; Wang H; Hu GX; Cai JP
    Drug Metab Dispos; 2015 Aug; 43(8):1246-9. PubMed ID: 25994031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Warfarin Metabolites in Patients Following Cardiac Valve Implantation: A Contribution of Clinical and Genetic Factors.
    Bryk A; Wypasek E; Awsiuk M; Maj D; Undas A
    Cardiovasc Drugs Ther; 2015 Jun; 29(3):257-64. PubMed ID: 25986145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Identification of a novel CYP2C9 gene mutation (1400T>C) and assessment of its enzymatic activity in vitro].
    Dai DP; Li CB; Wang SH; Geng PW; Hu GX; Cai JP
    Zhonghua Yi Xue Za Zhi; 2013 Nov; 93(44):3537-41. PubMed ID: 24521898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of Genetic Polymorphisms in the VKORC1 and CYP2C9 Genes with Warfarin Dosage in a Group of Kuwaiti Individuals.
    Alrashid MH; Al-Serri A; Alshemmari SH; Koshi P; Al-Bustan SA
    Mol Diagn Ther; 2016 Apr; 20(2):183-90. PubMed ID: 26940072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. First report of warfarin dose requirements in patients possessing the CYP2C9*12 allele.
    O'Brien TJ; Kidd RS; Richard CA; Ha NH; Witcher P; Tran LV; Barbour A; Tuck M; McIntosh SD; Douglas JN; Harralson AF
    Clin Chim Acta; 2013 Sep; 424():73-5. PubMed ID: 23688605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. VKORC1 and CYP2C9 genotypes in Egyptian patients with warfarin resistance.
    Azzam H; Elwakeel H; Awad I; El-Farahaty R; El-Gilany AH; El-Sharawy S
    Blood Coagul Fibrinolysis; 2016 Mar; 27(2):121-6. PubMed ID: 24978953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytochrome P450 2C9 gene polymorphism and warfarin maintenance dosage in pediatric patients: A systematic review and meta-analysis.
    Zhang J; Tian L; Huang J; Huang S; Chai T; Shen J
    Cardiovasc Ther; 2017 Feb; 35(1):26-32. PubMed ID: 27661060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of CYP2C9 and VKORC1 genetic polymorphisms upon warfarin dose requirements in Egyptian patients with acute coronary syndrome.
    Ghozlan MF; Foad DA; Darwish YW; Saad AA
    Blood Coagul Fibrinolysis; 2015 Jul; 26(5):499-504. PubMed ID: 25699611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between the CYP2C9 polymorphism and the drug metabolism phenotype.
    Topić E; Stefanović M; Samardzija M
    Clin Chem Lab Med; 2004 Jan; 42(1):72-8. PubMed ID: 15061384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of CYP2C9, VKORC1, and CYP4F2 polymorphisms on warfarin maintenance dose in children aged less than 18 years: a protocol for systematic review and meta-analysis.
    Takeuchi M; Kobayashi T; Brandão LR; Ito S
    Syst Rev; 2016 Jun; 5(1):105. PubMed ID: 27334984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of polymorphisms in the cytochrome P450 CYP2C9 with warfarin dose requirement and risk of bleeding complications.
    Aithal GP; Day CP; Kesteven PJ; Daly AK
    Lancet; 1999 Feb; 353(9154):717-9. PubMed ID: 10073515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Influence of warfarin related genes and non- genetic factors on administrative dose in Shanghai area].
    Zhuang W; Wu D; Wang Z
    Zhonghua Xue Ye Xue Za Zhi; 2014 Jan; 35(1):13-7. PubMed ID: 24602724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical effect of CYP2C9*5/*6 genotype on a patient's warfarin dose requirement.
    Quinn AL; Liko I; Lee JC
    Pharmacogenomics; 2017 Jul; 18(11):1051-1057. PubMed ID: 28685643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification and Enzymatic Activity Evaluation of a Novel
    Zhou XY; Lu XR; Li YH; Ma YQ; Zhao SW; Wang F; Xu RA; Hu GX; Cai JP
    Front Pharmacol; 2021; 12():619339. PubMed ID: 33643050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dependency of phenprocoumon dosage on polymorphisms in the VKORC1, CYP2C9, and CYP4F2 genes.
    Teichert M; Eijgelsheim M; Uitterlinden AG; Buhre PN; Hofman A; De Smet PA; Visser LE; Stricker BH
    Pharmacogenet Genomics; 2011 Jan; 21(1):26-34. PubMed ID: 21063236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Linkage disequilibrium between the CYP2C19*2,*17 and CYP2C9*1 alleles and impact of VKORC1, CYP2C9, CYP2C19 gene polymorphisms and gene-gene interactions on warfarin therapy.
    Khalighi K; Cheng G; Mirabbasi S; Khalighi B; Wu Y; Fan W
    J Thromb Thrombolysis; 2017 Jan; 43(1):124-129. PubMed ID: 27743182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High warfarin sensitivity in carriers of CYP2C9*35 is determined by the impaired interaction with P450 oxidoreductase.
    Lee MY; Borgiani P; Johansson I; Oteri F; Mkrtchian S; Falconi M; Ingelman-Sundberg M
    Pharmacogenomics J; 2014 Aug; 14(4):343-9. PubMed ID: 24322786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.